Position in IBRX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$22,587,289
+$18,635,989 QoQ
Shares Held
2,944,888
+47.6% QoQ
Ownership
0.281%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 96.0682715267949.ToString("F0")%
Shared 0.ToString("F0")%
None 3.9317284732050926.ToString("F0")%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,306,928,575 across 560 Biotechnology names. IBRX ranks #65 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in IBRX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $22,587,289 | 2,944,888 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $3,951,300 | 1,995,607 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $4,134,231 | 1,680,582 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,143,307 | 1,190,647 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,329,630 | 1,438,416 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,064,483 | 1,587,689 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,511,930 | 406,433 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,896,170 | 458,255 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4,969,875 | 925,489 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $214,414 | 42,712 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $67,231 | 39,782 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $110,399 | 39,712 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $208,167 | 114,378 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,868,816 | 368,603 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $576,111 | 115,918 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $186,271 | 50,073 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $970,696 | 173,030 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,158,320 | 354,987 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,714,527 | 278,699 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $388,115 | 27,179 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,329,771 | 56,014 | Shares | Defined | 2021-05-12 | |
| No filing history on record for this holder in this stock. | ||||||